Incannex Healthcare (IXHL) Total Current Liabilities (2020 - 2026)

Incannex Healthcare (IXHL) posted quarterly Total Current Liabilities of $1.9 million for Q1 2026, down 73.85% year-on-year from $7.4 million in Q1 2025, and up 24.56% on a QoQ basis from $1.5 million in Q4 2025.

Incannex Healthcare (IXHL) Total Current Liabilities (2020 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Total Current Liabilities for 7 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Total Current Liabilities fell 73.85% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (down 73.85% YoY) and the FY2025 annual result came in at $7.0 million, up 24.27% from the prior year.
  • Total Current Liabilities rose to $1.9 million in Q1 2026 per IXHL's latest filing, from $1.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for IXHL reached as high as $9.2 million in Q3 2024 and fell as low as $1.1 million in Q4 2022.
  • A 5-year average of $4.0 million and a median of $2.9 million in 2024 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 184.57% — and 2025, when it plunged 82.15%.
  • Year by year, Total Current Liabilities stood at $1.1 million in 2022, then soared by 184.57% to $3.2 million in 2023, then surged by 83.3% to $5.8 million in 2024, then plunged by 73.51% to $1.5 million in 2025, then grew by 24.56% to $1.9 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $1.9 million, $1.5 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - 1.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.93 Mn
Dec 31, 2025 1.55 Mn
Sep 30, 2025 1.65 Mn
Jun 30, 2025 6.98 Mn
Mar 31, 2025 7.37 Mn
Dec 31, 2024 5.84 Mn
Sep 30, 2024 9.23 Mn
Jun 30, 2024 5.62 Mn
Mar 31, 2024 2.86 Mn
Dec 31, 2023 3.19 Mn
Jun 30, 2023 2.55 Mn
Dec 31, 2022 1.12 Mn
Jun 30, 2022 2.01 Mn
Jun 30, 2021 755,049.00
Jun 30, 2020 1.07 Mn